These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3132497)

  • 1. Thrombolytic therapy and the new environment of medical practice.
    DeMaria AN
    J Am Coll Cardiol; 1988 Jul; 12(1):284-5. PubMed ID: 3132497
    [No Abstract]   [Full Text] [Related]  

  • 2. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F
    Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of thrombolytic therapy in acute myocardial infarction.
    Dutta AL; Mandal M
    J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptokinase...never again.
    van de Werf F
    Eur Heart J; 1999 Sep; 20(17):1215. PubMed ID: 10454969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy and angioplasty in myocardial infarction-- progress in the 1980s].
    Twardowski RM
    Kardiol Pol; 1990; 33(6):345-50. PubMed ID: 2084299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
    Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.
    Ramanathan K; Ellis CJ; White HD
    Drugs Aging; 1996 Apr; 8(4):237-44. PubMed ID: 8920173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 11. Another coronary reperfusion regimen.
    Simoons ML
    Lancet; 1995 Aug; 346(8971):324-5. PubMed ID: 7623525
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy.
    Collen D; Stump DC; Gold HK
    Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elements of choice of thrombolytic agents in myocardial infarction].
    Samama M; Brochet E; Valère PE
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic therapy with ultra-high doses of streptokinase].
    Köhler M; Doenecke P; Hellstern P; Schwerdt H; Winter R; Ozbek C; Scheffler P; Knobloch W; von Blohm G; Keller HE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):62-74. PubMed ID: 2427417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombolytic therapy in acute myocardial infarction--update].
    Jaffe R; Gotsman MS; Zahger D
    Harefuah; 1996 Jun; 130(11):751-7. PubMed ID: 8794679
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction.
    Kellett J; Clarke J
    Med Decis Making; 1995; 15(4):297-310. PubMed ID: 8544674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.